ELASTATHERAPY Trademark
Trademark Overview
On Monday, February 5, 2024, a trademark application was filed for ELASTATHERAPY with the United States Patent and Trademark Office. The USPTO has given the ELASTATHERAPY trademark a serial number of 98391875. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 18, 2024. This trademark is owned by Allergan Pharmaceuticals International Limited. The ELASTATHERAPY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations
General Information
| Serial Number | 98391875 |
| Word Mark | ELASTATHERAPY |
| Filing Date | Monday, February 5, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, November 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 5, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Allergan Pharmaceuticals International Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Dublin 17 D17E400
IE |
Trademark Events
| Event Date | Event Description |
| Monday, February 5, 2024 | NEW APPLICATION ENTERED |
| Monday, June 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 29, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, August 29, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2024 | ASSIGNED TO EXAMINER |
| Monday, November 11, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 11, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 11, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 12, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
